Torno Capital, LLC Iovance Biotherapeutics, Inc. Call Options Transaction History

Torno Capital, LLC

2 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q1 2024 May 15, 2024	SELL	$7.59 - $17.47 $379,500 - $873,500	-50,000 Reduced 83.33%	10,000 $148 Million
Q4 2023 Feb 14, 2024	BUY	$3.3 - $8.89 $198,000 - $533,400	60,000 New	60,000 $488 Million

315

222M

3.05M

1.6M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.46B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Torno Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Torno Capital, LLC with notifications on news.